{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T13:12:13Z","timestamp":1785157933943,"version":"3.55.0"},"reference-count":36,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2007,8,1]],"date-time":"2007-08-01T00:00:00Z","timestamp":1185926400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2007,8,1]],"date-time":"2007-08-01T00:00:00Z","timestamp":1185926400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["molpharm.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Pharmacology"],"published-print":{"date-parts":[[2007,8]]},"DOI":"10.1124\/mol.106.033746","type":"journal-article","created":{"date-parts":[[2007,5,9]],"date-time":"2007-05-09T17:15:05Z","timestamp":1178730905000},"page":"291-302","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":88,"title":["A Novel Multivalent Ligand That Bridges the Allosteric and Orthosteric Binding Sites of the M2 Muscarinic Receptor"],"prefix":"10.1016","volume":"72","author":[{"given":"Tod","family":"Steinfeld","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathai","family":"Mammen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacqueline A.M.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard D.","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey R.","family":"Jasper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/mol.106.033746_REF1","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1111\/j.1476-5381.1959.tb00928.x","article-title":"Some quantitative uses of drug antagonists","volume":"14","author":"Arunlakshana","year":"1959","journal-title":"Br J Pharmacol Chemother"},{"key":"10.1124\/mol.106.033746_REF2","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1124\/jpet.103.059840","article-title":"Application of a kinetic model to the apparently complex behavior of negative and positive allosteric modulators of muscarinic acetylcholine receptors","volume":"308","author":"Avlani","year":"2004","journal-title":"J Pharmacol Exp Ther"},{"issue":"Suppl 12A","key":"10.1124\/mol.106.033746_REF3","first-page":"24S","article-title":"The role of anticholinergics in chronic obstructive pulmonary disease","volume":"117","author":"Barnes","year":"2004","journal-title":"Am J Med"},{"key":"10.1124\/mol.106.033746_REF4","doi-asserted-by":"crossref","first-page":"2517","DOI":"10.1016\/S0024-3205(01)01047-5","article-title":"Multiple allosteric sites on muscarinic receptors","volume":"68","author":"Birdsall","year":"2001","journal-title":"Life Sci"},{"key":"10.1124\/mol.106.033746_REF5","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/0896-6273(88)90190-0","article-title":"Cloning and expression of the human and rat m5 muscarinic acetylcholine receptor genes","volume":"1","author":"Bonner","year":"1988","journal-title":"Neuron"},{"key":"10.1124\/mol.106.033746_REF6","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/0163-7258(93)90027-B","article-title":"Muscarinic receptor\u2014characterization, coupling and function","volume":"58","author":"Caulfield","year":"1993","journal-title":"Pharmacol Ther"},{"key":"10.1124\/mol.106.033746_REF7","doi-asserted-by":"crossref","first-page":"3099","DOI":"10.1016\/0006-2952(73)90196-2","article-title":"Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction","volume":"22","author":"Cheng","year":"1973","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/mol.106.033746_REF8","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1124\/pr.54.2.323","article-title":"G protein-coupled receptor allosterism and complexing","volume":"54","author":"Christopoulos","year":"2002","journal-title":"Pharmacol Rev"},{"key":"10.1124\/mol.106.033746_REF9","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1111\/j.1476-5381.1976.tb07708.x","article-title":"The inhibitory effect of gallamine on muscarinic receptors","volume":"58","author":"Clark","year":"1976","journal-title":"Br J Pharmacol"},{"key":"10.1124\/mol.106.033746_REF10","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1021\/jm050769s","article-title":"Design, synthesis, and action of oxotremorine-related hybrid-type allosteric modulators of muscarinic acetylcholine receptors","volume":"49","author":"Disingrini","year":"2006","journal-title":"J Med Chem"},{"key":"10.1124\/mol.106.033746_REF11","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/S0165-6147(00)01737-5","article-title":"Therapeutic opportunities from muscarinic receptor research","volume":"22","author":"Eglen","year":"2001","journal-title":"Trends Pharmacol Sci"},{"key":"10.1124\/mol.106.033746_REF12","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0026-895X(25)13145-3","article-title":"Estimation of the affinities of allosteric ligands using radioligand binding and pharmacological null methods","volume":"33","author":"Ehlert","year":"1988","journal-title":"Mol Pharmacol"},{"key":"10.1124\/mol.106.033746_REF13","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1016\/0006-2952(91)90591-R","article-title":"Allosteric regulation of cloned m1-m5 muscarinic receptor subtypes","volume":"42","author":"Ellis","year":"1991","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/mol.106.033746_REF14","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/S0026-895X(25)09006-6","article-title":"Two allosteric modulators interact at a common site on cardiac muscarinic receptors","volume":"42","author":"Ellis","year":"1992","journal-title":"Mol Pharmacol"},{"key":"10.1124\/mol.106.033746_REF15","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/S0026-895X(25)13228-8","article-title":"Use of chimeric muscarinic receptors to investigate epitopes involved in allosteric interactions","volume":"44","author":"Ellis","year":"1993","journal-title":"Mol Pharmacol"},{"key":"10.1124\/mol.106.033746_REF16","doi-asserted-by":"crossref","first-page":"12222","DOI":"10.1073\/pnas.96.22.12222","article-title":"Delineating muscarinic receptor functions","volume":"96","author":"Gainetdinov","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1124\/mol.106.033746_REF17","first-page":"40","article-title":"Antimuscarinics for the treatment of overactive bladder: current options and emerging therapies","volume":"5","author":"Hegde","year":"2004","journal-title":"Curr Opin Investig Drugs"},{"key":"10.1124\/mol.106.033746_REF18","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1146\/annurev.pa.30.040190.003221","article-title":"Muscarinic receptor subtypes","volume":"30","author":"Hulme","year":"1990","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1124\/mol.106.033746_REF19","doi-asserted-by":"crossref","unstructured":"Katzenschlager R, Sampaio C, Costa J, and Lees A (2003) Anticholinergics for symptomatic management of Parkinson\u2019s disease. Cochrane Database Syst Rev (2):CD003735.","DOI":"10.1002\/14651858.CD003735"},{"key":"10.1124\/mol.106.033746_REF20","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1038\/27227","article-title":"Spanning binding sites on allosteric proteins with polymer-linked ligand dimers","volume":"395","author":"Kramer","year":"1998","journal-title":"Nature"},{"key":"10.1124\/mol.106.033746_REF21","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/S0026-895X(25)10255-1","article-title":"Detection, quantitation, and verification of allosteric interactions of agents with labeled and unlabeled ligands at G protein-coupled receptors: interactions of strychnine and acetylcholine at muscarinic receptors","volume":"48","author":"Lazareno","year":"1995","journal-title":"Mol Pharmacol"},{"key":"10.1124\/mol.106.033746_REF22","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/S0026-895X(25)10214-9","article-title":"Role of acidic amino acids in the allosteric modulation by gallamine of antagonist binding at the m2 muscarinic acetylcholine receptor","volume":"45","author":"Leppik","year":"1994","journal-title":"Mol Pharmacol"},{"key":"10.1124\/mol.106.033746_REF23","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/S0165-6147(00)89066-5","article-title":"Analysis of competitive agonist-antagonist interactions by nonlinear regression","volume":"16","author":"Lew","year":"1995","journal-title":"Trends Pharmacol Sci"},{"key":"10.1124\/mol.106.033746_REF24","doi-asserted-by":"crossref","first-page":"2754","DOI":"10.1002\/(SICI)1521-3773(19981102)37:20<2754::AID-ANIE2754>3.0.CO;2-3","article-title":"Polyvalent interactions in biological systems: implications for design and use of multivalent ligands and inhibitors","volume":"37","author":"Mammen","year":"1998","journal-title":"Angewandte Chemie Int Ed"},{"key":"10.1124\/mol.106.033746_REF25","doi-asserted-by":"crossref","first-page":"3821","DOI":"10.1021\/jo970944f","article-title":"Estimating the entropic cost of self-assembly of multiparticle hydrogen-bonded aggregates based on the cyanuric acid-melamine lattice","volume":"63","author":"Mammen","year":"1998","journal-title":"J Org Chem"},{"key":"10.1124\/mol.106.033746_REF26","doi-asserted-by":"crossref","first-page":"3168","DOI":"10.1021\/jo970943n","article-title":"Using a convenient, quantitative model for torsional entropy to establish qualitative trends for molecular processes that restrict conformational freedom","volume":"63","author":"Mammen","year":"1998","journal-title":"J Org Chem"},{"key":"10.1124\/mol.106.033746_REF27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1146\/annurev.pharmtox.47.120505.105159","article-title":"Allosteric modulation of g protein-coupled receptors","volume":"47","author":"May","year":"2007","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1124\/mol.106.033746_REF28","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.pupt.2004.03.001","article-title":"The airway cholinergic system: physiology and pharmacology","volume":"17","author":"Racke","year":"2004","journal-title":"Pulmonary Pharmacology & Therapeutics"},{"key":"10.1124\/mol.106.033746_REF29","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1126\/science.280.5364.708","article-title":"A trivalent system from vancomycin. d-Ala-d-Ala with higher affinity than avidin. Biotin","volume":"280","author":"Rao","year":"1998","journal-title":"Science"},{"key":"10.1124\/mol.106.033746_REF30","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1124\/mol.105.019257","article-title":"Evidence for a multivalent interaction of symmetrical, N-linked, lidocaine dimers with voltage-gated Na+ channels","volume":"69","author":"Smith","year":"2006","journal-title":"Mol Pharmacol"},{"key":"10.1124\/mol.106.033746_REF31","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1006\/bulm.1997.0009","article-title":"Parallel dose-response curves in combination experiments","volume":"60","author":"Suhnel","year":"1998","journal-title":"Bull Math Biol"},{"key":"10.1124\/mol.106.033746_REF32","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1124\/mol.51.4.674","article-title":"Divergent modes of action among cationic allosteric modulators of muscarinic m2 receptors","volume":"51","author":"Trankle","year":"1997","journal-title":"Mol Pharmacol"},{"key":"10.1124\/mol.106.033746_REF33","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0165-6147(00)89023-9","article-title":"Allosteric modulation of muscarinic acetylcholine receptors","volume":"16","author":"Tu\u010dek","year":"1995","journal-title":"Trends Pharmacol Sci"},{"key":"10.1124\/mol.106.033746_REF34","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1124\/mol.64.1.21","volume":"64","author":"Voigtl\u00e4nder","year":"2003","journal-title":"Mol Pharmacol"},{"key":"10.1124\/mol.106.033746_REF35","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/0165-6147(93)90049-P","article-title":"Molecular basis of muscarinic acetylcholine receptor function","volume":"14","author":"Wess","year":"1993","journal-title":"Trends Pharmacol Sci"},{"key":"10.1124\/mol.106.033746_REF36","unstructured":"Wheatley M, Hulme EC, Birdsall NJ, Curtis CA, Eveleigh P, Pedder EK, and Poyner D (1988) Peptide mapping studies on muscarinic receptors: receptor structure and location of the ligand binding site. Trends Pharmacol Sci Suppl: 19-24."}],"container-title":["Molecular Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026895X24045188?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026895X24045188?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/mol.106.033746","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T11:53:51Z","timestamp":1739966031000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0026895X24045188"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,8]]},"references-count":36,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2007,8]]}},"alternative-id":["S0026895X24045188"],"URL":"https:\/\/doi.org\/10.1124\/mol.106.033746","relation":{},"ISSN":["0026-895X"],"issn-type":[{"value":"0026-895X","type":"print"}],"subject":[],"published":{"date-parts":[[2007,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A Novel Multivalent Ligand That Bridges the Allosteric and Orthosteric Binding Sites of the M2 Muscarinic Receptor","name":"articletitle","label":"Article Title"},{"value":"Molecular Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/mol.106.033746","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2007 The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}